Pancreatic cancer: challenges and opportunities in locoregional therapies
Simple Summary Pancreatic cancer is a serious ongoing global health burden, with an
overall 5-year survival rate of less than 5%. One major hurdle in the treatment of this disease …
overall 5-year survival rate of less than 5%. One major hurdle in the treatment of this disease …
[HTML][HTML] Clinical efficacy and safety of irreversible electroporation combined with chemotherapy in stage IV pancreatic cancer treatment
J Zeng, B Liu, X Lang, Z Wang, Y Fan… - Journal of Cancer …, 2024 - journals.lww.com
Purpose: This study evaluates the clinical efficacy and safety of irreversible electroporation
(IRE) therapy combined with chemotherapy in patients with stage IV pancreatic cancer …
(IRE) therapy combined with chemotherapy in patients with stage IV pancreatic cancer …
[HTML][HTML] Percutaneous irreversible Electroporation in Locally Advanced Pancreatic Cancer: A Review of Current Literature
S Carriero, C Lanza, G Pellegrino, C Sattin… - Journal of Cancer …, 2023 - fortuneonline.org
Pancreatic cancer (PC) is a highly lethal disease with a 5-year survival rate of 5-6%. To date,
the only potentially curative option for PC remains surgical resection with microscopically …
the only potentially curative option for PC remains surgical resection with microscopically …
[PDF][PDF] Irreversible electroporation in pancreatic cancer: Past experience, present challenges and future perspectives
RV Flak - 2022 - vbn.aau.dk
Pancreatic cancer (PC) is a detrimental disease with few treatment options for most patients.
The global incidence is rising, and advances in treatment are merely incremental when …
The global incidence is rising, and advances in treatment are merely incremental when …
[PDF][PDF] Irreversible electroporation in pancreatic cancer
RV Flak - vbn.aau.dk
Pancreatic cancer (PC) is a detrimental disease with few treatment options for most patients.
The global incidence is rising, and advances in treatment are merely incremental when …
The global incidence is rising, and advances in treatment are merely incremental when …